Podchaser Logo
Home
Life Sciences Connect

Deloitte LLP

Life Sciences Connect

A monthly Business podcast
Good podcast? Give it some love!
Life Sciences Connect

Deloitte LLP

Life Sciences Connect

Episodes
Life Sciences Connect

Deloitte LLP

Life Sciences Connect

A monthly Business podcast
Good podcast? Give it some love!
Rate Podcast

Episodes of Life Sciences Connect

Mark All
Search Episodes...
Europe faces substantial challenges in continuing to deliver high-quality healthcare services to its citizens. With growing populations, rigid financing models and rising health inequalities, the conventional, reactive 'sick care' model needs
In episode 27 of the Life Sciences Connect Podcast, we speak to the authors of the Time to Change report and discuss the current state of the UK healthcare workforce, touching on topics including pay, diversity, work-life balance, and trainin
In Episode 26, our panel of industry experts dive into the key trends and challenges facing the consumer health industry. This is one not to miss. With increased access to information, greater levels of choice and improved functionality of prod
Tune in to the latest episode of the Life Sciences Connect podcast, where you will find Sara Siegel’s fireside chat about all things Global Healthcare Episode 25 welcomes the new Global Head of Health and previous guest, Sara Siegel who discuss
Karen and the team explore the findings from the Future of Diagnostic Series   Episode 24 podcast explores some of the themes highlighted in our two reports on the future of diagnostics and specifically how the adoption of innovation and new m
Listen to episode twenty-three to hear Karen, and our guests dissect the findings from the latest annual R&D ROI Report which launched last month. This report has provided insights into the state of biopharma R&D since 2010. We have expanded th
In episode twenty-two, we explore the challenges facing UK government and public services. Tune in as our experts discuss the issues currently facing health and social care, from unsustainable levels of funding to longstanding pressures on the
On this episode of Life Sciences Connect podcast, we bring the discussion of emission reduction to the forefront. Hear our guest discuss further: James Gregson – UK’s Life Sciences & Healthcare industry leader At the start of October we launche
On this episode of Life Sciences Connect podcast, we discuss these issues further with our panel of experts: Andy Flockhart, UK MedTech Leader Guido Baechler, CEO of Mainz Biomed And of course, our host, Karen Taylor, Research Director, Centr
Episode 19 of the Life Sciences Connect podcast sheds light on the important topic of Health equity and dives into discussions around what this really means, what businesses can do to improve this, how diversity groups are affected and much mor
Listen to episode 18 of the Life Sciences Connect podcast where we talk to specialists about Hospital Activation, how we are breaking from the traditional approach and what the future holds.
Listen to episode 17 of the Life Sciences Connect podcast here where we continue with the Future of Public Health series and dive further into the report- Evaluating the role of employers in reducing the public health gap: Improving the health
In episode sixteen of the Life Science Connect podcast, we dive into the conversation around our fourth report in our Future of Public Health series; Negating the gap - Preventing ill health and promoting healthy behaviours. Joining our host Ka
In episode fifteen of the Life Science Connect podcast, we dive into the conversation around our annual R&D Measuring the return from pharmaceutical innovation series report. This report analyses the projected return on investment that biopharm
In episode fourteen of the Life Science Connect podcast, we dive into the conversation around planetary health and sustainability in healthcare. Following COP26, it is important that we discuss points around the fundamental risk of climate chan
In our thirteenth episode of the Life Science Connect podcast series, we discuss the findings from The Future of Public Health Series, covered in the overview report: Narrowing the gap: A fairer and more sustainable future for public health. Th
In our twelfth episode of Life Sciences Connect, our host, Karen Taylor, the Research Director of the Centre for Health Solutions talks to Hanno Ronte, Partner at Monitor Deloitte about consumer research conducted this year on trust in the phar
In our eleventh episode of Life Sciences Connect, we talk to Karen Taylor, Research Director of the Deloitte Centre for Health Solutions who is joined by Thomas Croisier, Consulting Partner, Deloitte France; Deborshi Dutt, Consulting Partner, D
In our tenth episode of Life Sciences Connect, we talk to Karen Taylor, Research Director of the Deloitte Centre for Health Solutions who is joined by Naveed Panjwani, Director, Consulting, Deloitte and Kevin Dondarski, Senior Manager, Consulti
Our ninth episode of Life Sciences Connect series explores the key trends for the Medtech industry including the rise in consumer organisations entering the space, the evolution from product to service, the changing regulatory landscape, and th
James Gregson, our newly appointed UK Life Sciences and Healthcare leader, joins our episode host Samrina Bhatti, to share his thoughts  on what’s next for the industry. James talks about his  leadershipstyle and what makes a good leader as wel
What lies ahead for patients, your organisation and your workforce? In this podcast, we explore our predictions for the life sciences and health care industry in 2025, how the pandemic has accelerated industry trends and what this means for you
C-suite leaders in pharmaceutical companies increasingly view Real World Evidence (RWE) as strategically important. RWE enables R&D organisations to prioritise their pipeline investments more effectively, better understand underlying causes of
Healthcare systems across Europe face rising pressures – particularly the increasing healthcare needs due to growing and ageing populations, multi-morbidity, and public expectations of more personalised and convenient services. Many clinicians
The Biotech sector is a key player in driving biopharma innovation and developing ground-breaking treatments for patients. Supporting the growth of this sector is vital to ensure that R&D efforts continue, both now and in the future. However, l
Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features